Surmodics (SRDX)
(Real Time Quote from BATS)
$32.11 USD
-0.21 (-0.65%)
Updated May 10, 2024 03:06 PM ET
3-Hold of 5 3
D Value F Growth B Momentum D VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Bottom 43% (142 out of 250)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.50 | 1.69 | 9.99 |
Current Quarter Estimate | -0.30 | 5.88 | 57.00 |
Year Ago Quarter Estimate | 0.52 | 4.88 | 52.54 |
Next Quarter Estimate | -0.27 | 7.06 | 61.00 |
Next Year Estimate | -0.02 | 39.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -550.00 | 17.70 | 15.67 |
Next Year | 97.22 | 24.10 | 9.31 |
Last 5 Years | -22.90 | 4.00 | 8.10 |
Next 5 Years | NA | 10.80 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 28.86 | -13.85 |
Price/Book (MRQ) | 3.72 | 1.92 |
Price/Cash Flow (MRFY) | 41.22 | 11.24 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 9.44% | 9.56% |
Return on Equity (TTM) | 13.30% | 13.06% |
Debt to Equity (MRQ) | 0.24 | 26.41 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.